The Global Breast Cancer Market Report by Koncept Analytics provides comprehensive. For more mail me: vikas@konceptanalytics.com

1. Global Breast Cancer Market Report
-----------------------------------------
2014
View Report Details

2. Executive Summary
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women.
Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The
most common risk factors for breast cancer are being female and growing older.
In the past few years, the cases of breast cancer have increased tremendously in regions like the US and the
Europe. The breast cancer market is driven by various factors like aging population in women, obesity and
diabetes, hormonal factors, race and ethnicity and family history. A major trend which will probably remain
eternally in the breast cancer treatment industry is the fact that novel and innovative technologies and
pharmaceutical molecules are always under development. Challenges associated with breast cancer are like
costs of treatment, regulatory measures and adverse effects of the treatment on patients.
The market for breast cancer drugs represents an area of potential opportunity in both developed and
developing countries. Due to effectiveness and advancements in technology, a large number of companies
are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and
agreements to develop effective treatment methods for breast cancer.
The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment
market with focus on regions like the US, India, China and Brazil. Furthermore, market dynamics such as the
industry trends and development, the underlying growth drivers and major issues faced by the industry are
elicited. On the contention front, the market is personified by the intense competition in terms of research and
development of novel therapeutic molecules. The leading players operating in the industry include Hologic,
Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.
View Report Details

3. Breast cancer is the most commonly diagnosed cancer in women. Cancer cases have been increasing at a
rate of 3.1% per year ………………….
 The global oncology sales were US$.... billion in 2012
which are poised to reach US$ billion in 2014.
 The global market for predictive breast cancer diagnostic
and drug technologies can be divided into four
categories .
 The US breast imaging systems market generated
revenues worth US$... billion in 2012 which is reckoned
to reach US$.... billion in 2014.
 The median age for a breast cancer diagnosis in White
women in the US. is 61, for African American women it is
57.
2010 2011 2012 2013E 2014E
US$Million
Global Breast Cancer Market by Segments (2013E)
2010 2011 2012 2013E 2014E
US$Billion
Global Oncology Spending (2010-2014E)
The US Breast Imaging Systems Market (2010-2014E)
Breast Cancer Drugs
Quantitative immunoflourescence
Genomic analysis
IHC and FISH

4. Global Breast Cancer Market Report
 The breast cancer imaging market in China is expected to
grow from a value of US$...million in 2012 to US$... million in
2014, at a CAGR of ..%.
 According to the World Health Organization, low survival
rates in less developed countries are due to a lack of early
detection programs in concert with a lack of adequate
diagnosis and treatment facilities.
 The Indian breast cancer imaging market is anticipated to
grow from US$... million in 2012 to US$...million by 2014 at a
CAGR of …%.
India’s Breast Screening Market (2010-2014E)
Brazil’s Breast Cancer Imaging Market (2010-2014E)
2010 2011 2012 2013E 2014E
US$Million
China’s Breast Screening Market (2010-2014E)
2010 2011 2012 2013E 2014E
US$Million
2010 2011 2012 2013E 2014E
US$Million

5. Therapeutics market is one of the fastest growing markets globally. The rising ageing population along with increasing
prevalence of chronic diseases such as, cancer, diabetes, cardiovascular diseases, and rising penetration of medical
insurance are some of the prominent factors that are driving the superfluous growth of the industry.
• The US had the largest breast cancer therapeutics market in 2013, valued at US$... billion, equivalent to a global share of
….%.
• Canada had the lowest market share but is expected to witness rapid growth during 2014-2020 with a CAGR of ….%.
• More than one billion adults are overweight worldwide and at least 25% of the overweight population is obese, which is a
one of the risk factors for breast cancer.
• According to the American Cancer Society, about 1 out of 8 invasive breast cancers develop in women younger than 45.
About 2 out of 3 invasive breast cancers are found in women 55 or older.
Breast Cancer Therapeutics Market by Region
US Japan Italy Canada Others

6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Breast Cancer Market
Report”. To know more about this report or for any customized research requirement, please contact the following:
View Report Details